We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 334

CMS considers linking Medicare drug payment rates to international prices
  • Hogan Lovells
  • USA
  • October 30 2018

On October 25, 2018, the Centers for Medicare & Medicaid Services (CMS) issued an Advance Notice of Proposed Rulemaking (ANPRM) describing a potential


Boots on the Ground: PIL Task Force Targeting Opioid Providers in the War on Drugs
  • K&L Gates
  • USA
  • April 30 2018

Attorney General Jeff Sessions announced the creation of the Prescription Interdiction & Litigation (“PIL”) Task Force -- which Sessions described as


First-Of-Its-Kind Decision: Medicare Will Now Cover Certain Diagnostic Tests Utilizing Next Generation Sequencing for Cancer
  • Arent Fox LLP
  • USA
  • March 29 2018

As a result of the FDA-CMS Parallel Review Program, and representing a first-of-its-kind decision, the Centers for Medicare & Medicaid Services (CMS)


OIG Wants CMS to Track Medicare Costs from Device Failures
  • Reed Smith LLP
  • USA
  • October 27 2017

A recent Office of Inspector General (OIG) report suggests that the lack of medical device-specific information on Medicare claim forms complicates


CNN Investigates Expanding Use of Nuedexta in Nursing Homes
  • Stark & Stark
  • USA
  • October 16 2017

A recent investigation by CNN brought to light the expanding and allegedly inappropriate use of the prescription drug Nuedexta in nursing homes


Senate Confirms Dr. Gottlieb's Nomination as FDA Commissioner
  • Jones Day
  • USA
  • May 12 2017

On May 9, 2017, the Senate confirmed Dr. Scott Gottlieb as the next FDA commissioner. With a 57-42 vote, the Senate fills the commissioner position


Third Circuit Affirms Dismissal of FCA Suit Against Genentech Based on Supreme Court’s Materiality Standard
  • McDermott Will & Emery
  • USA
  • May 10 2017

On May 1, 2017, the US Court of Appeals for the Third Circuit affirmed the dismissal of United States ex rel. Petratos, et al. v. Genentech, Inc., et


Third Circuit joins other circuits in enforcing Escobar's strict materiality requirement
  • DLA Piper
  • USA
  • May 4 2017

The Third Circuit has affirmed the district court's dismissal of a relator's claims in United States ex rel. Petratos, et al. V. Genentech Inc, et al


Three Senators Urge Health and Human Services Secretary to Use Statutory Authority to Allow Drugs from Canada
  • Sidley Austin LLP
  • USA
  • February 17 2017

On Feb. 14, Sens. Charles Grassley, R-Iowa, John McCain, R-Ariz., and Amy Klobuchar, D-Minn., issued a letter to Health and Human Services Secretary


Health Law Update - December 1, 2016
  • Baker & Hostetler LLP
  • USA
  • December 1 2016

Welcome to this week's edition of the Health Law Update. In this Issue...